关键数据
0.750今开
0.770最高
0.00成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.05%换手率
0.759昨收
0.735最低
0.00成交额
亏损市盈率静
1.14市净率
0.00%股息率 TTM
-107.86%ROA
2.56552周最高
0.70量比
-32.01M净利润
46.84M总股本
-0.6984每股收益TTM
0.75Beta
-142.60%ROE
0.63052周最低
7.33%振幅
-43.70%毛利率
35.18M总市值
9.92回报/风险
3.92%风险率

即将为您带来更多新闻,敬请期待。。。
InspireMD Inc评分
-0.04与上次评分对比预测8.00
财务诊断5.88
技术分析4.26
公司估值8.38
机构认同度3.00
风险评估3.03
分析师评级
买入评级
3.333目标均价
+339.23%涨幅空间
InspireMD Inc 最新财报电话会记录
InspireMD (NSPR) 2026财年第二季度业绩电话会议:召回影响与FDA催化剂
InspireMD 2026年第二季度营收为180万美元,召回费用使利润率承压。国际销售额增长21%,关键的FDA决定预计将于第四季度做出。
财务指标
货币: USD

由于公司未披露,未能获取相关数据
货币: USD

由于公司未披露,未能获取相关数据
InspireMD Inc 简介
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.
行业医疗设备与耗材
公司代码NSPR
员工数量85
国家United States of America
持股情况
| 持股股东 | 占比 |
|---|
| Rosalind Advisors, Inc. | 8.34% |
|---|
| Nantahala Capital Management, LLC | 7.21% |
|---|
| abrdn Inc. | 6.78% |
|---|
| OrbiMed Advisors, LLC | 6.69% |
|---|
| 股东类型 | 占比 |
|---|
| Hedge Fund | 24.88% |
|---|
| Individual Investor | 20.36% |
|---|
| Investment Advisor/Hedge Fund | 16.50% |
|---|
| Private Equity | 6.69% |
|---|
常见问题
InspireMD Inc(NSPR)的当前股价是多少?
InspireMD Inc(NSPR)的当前股价是 0.75。
InspireMD Inc股票的52周最高点是多少?
InspireMD Inc股票的52周最高点是2.56。
InspireMD Inc股票的52周最低点是多少?
InspireMD Inc股票的52周最低点是0.63。
现在InspireMD Inc(NSPR)的股票是买入、持有还是卖出?
根据分析师评级,InspireMD Inc(NSPR)的总体评级为买入,目标价格为3.33。
InspireMD Inc(NSPR)股票的每股收益(EPS TTM)是多少
InspireMD Inc(NSPR)股票的每股收益(EPS TTM)是-0.70。